September 8, 2008 Italy
Diamyd research well-represented at respected international diabetes conference
Results from clinical studies with the Diamyd® diabetes vaccine are being presented on three different posters at the annual meeting of the European Association for the Study of Diabetes (EASD) held in Rome on September 7-11, 2008.
"The fact that all three posters have been selected by the EASD shows the success and high quality of Diamyd® research. This recognition by the academic world and its diabetes specialists provides a stable foundation for our international business affairs", comments Elisabeth Lindner, President and CEO of Diamyd Medical.
The posters are presented on September 8, 2008.
For more information, please contact:
Elisabeth Lindner, President and CEO Diamyd Medical AB (publ.), elisabeth.lindner@diamyd.com
Phone: +46-8-661 0026
For pictures and press material, please contact:
Sonja Catani, Chief Communications Officer Diamyd Medical AB (publ), sonja.catani@diamyd.com
Phone: +46-8-661 00 26
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.